As the ADC landscape become increasingly crowded around established payload mechanisms and targets, leveraging chemistry and technological innovation is crucial to pursue novel ADC payloads and targeting moieties to develop differentiated ADCs that provide long-term patient benefit

Join this popular seminar day to stay ahead of the ADC design curve across discovery and performance of non-cytotoxic payloads, bispecific and fragment-conjugates, and dual payload ADCs